NIMH Clinical Trial Applications for Early Stage Testing of Pharmacologic and Neuromodulatory Interventions
National Institutes of Health
Description
This grant opportunity supports early stage testing of new pharmacologic or device-based interventions to treat symptoms in individuals with mental illnesses such as schizophrenia, depression, autism, OCD, anxiety, and bipolar disorder. It encourages studies that intervene early when symptoms first appear, even if full diagnostic criteria are not yet met. The aim is to evaluate these interventions by testing their presumed mechanisms of action to achieve well-controlled, dose-dependent effec…
The purpose of this NOFO is to support the early stage testing of pharmacologic interventions with novel mechanisms of action or neuromodulatory device-based interventions for the treatment of symptoms or domains of altered functions in individuals with mental illness (e.g., schizophrenia, depre…
Source
Grant ID
PAR-25-184
Agency
National Institutes of Health
Subcategory/Subagency
National Institute of Mental Health
Key Dates
Opportunity Released
November 26, 2024
Eligibility
The following categories of applicants are invited to apply:
- Public/State-Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofit Organizations with 501(c)(3) status (other than Institutions of Higher Education)
- Nonprofit Organizations without 501(c)(3) status (other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- U.S. Territories or Possessions
- Regional Organizations
- Faith-based or Community-based Organizations
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Eligible Agencies of the Federal Government
- Non-domestic (non-U.S.) Entities (Foreign Organizations)
- Non-domestic (non-U.S.) components of U.S. Organizations (eligible to apply)
- Foreign components (as defined in NIH Grants Policy Statement) are allowed
Similar opportunities
- Early-Stage Testing of Pharmacologic or Neuromodulatory Device-Based Interventions for Mental Illness (R33 Clinical Trial Required)
National Institutes of Health
- NIMH Clinical Trial Funding Opportunity for Efficacy Testing of Interventions
National Institutes of Health
- NIMH Clinical Trial Pilot Research on Novel Psychosocial Interventions
National Institutes of Health
- NIMH Clinical Trial Pilot Studies for Novel Psychosocial Interventions
National Institutes of Health
- Mechanistic and Translational Research on Mood and Psychotic Disorders During the Menopausal Transition (R21 Clinical Trial Optional)
National Institutes of Health